NIH Trial of Six-Strain Universal Flu Vaccine Candidate Begins
The nanoparticle vaccine candidate, FluMos-v2, builds on its predecessor FluMos-v1 and is designed to induce antibodies against six flu strains.
The nanoparticle vaccine candidate, FluMos-v2, builds on its predecessor FluMos-v1 and is designed to induce antibodies against six flu strains.
Some signs point to an early start for flu season, with cases already ticking up in parts of the country.